Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kibem Kim"'
Autor:
Sara R. Alcorn, Anna W. LaVigne, Christen R. Elledge, Jacob Fiksel, Chen Hu, Lawrence Kleinberg, Adam Levin, Thomas Smith, Zhi Cheng, Kibem Kim, Avani D. Rao, Lindsey Sloan, Brandi Page, Susan F. Stinson, K. Ranh Voong, Todd R. McNutt, Michael R. Bowers, Theodore L. DeWeese, Scott Zeger, Jean L. Wright
Publikováno v:
JCO Clinical Cancer Informatics.
PURPOSE The Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP) provides patient-specific survival predictions and evidence-based recommendations to guide multidisciplinary management for symptomatic bone metastases. We
Autor:
Zhihao, Lu, Jianling, Zou, Shuang, Li, Michael J, Topper, Yong, Tao, Hao, Zhang, Xi, Jiao, Wenbing, Xie, Xiangqian, Kong, Michelle, Vaz, Huili, Li, Yi, Cai, Limin, Xia, Peng, Huang, Kristen, Rodgers, Beverly, Lee, Joanne B, Riemer, Chi-Ping, Day, Ray-Whay Chiu, Yen, Ying, Cui, Yujiao, Wang, Yanni, Wang, Weiqiang, Zhang, Hariharan, Easwaran, Alicia, Hulbert, KiBem, Kim, Rosalyn A, Juergens, Stephen C, Yang, Richard J, Battafarano, Errol L, Bush, Stephen R, Broderick, Stephen M, Cattaneo, Julie R, Brahmer, Charles M, Rudin, John, Wrangle, Yuping, Mei, Young J, Kim, Bin, Zhang, Ken Kang-Hsin, Wang, Patrick M, Forde, Joseph B, Margolick, Barry D, Nelkin, Cynthia A, Zahnow, Drew M, Pardoll, Franck, Housseau, Stephen B, Baylin, Lin, Shen, Malcolm V, Brock
Publikováno v:
Nature. 579(7798)
Cancer recurrence after surgery remains an unresolved clinical problem
Autor:
Bert Vogelstein, Ren Yuan Bai, Gregory J. Riggins, Paul B. Rothman, Nickolas Papadopoulos, Marco L. Davila, Verena Staedtke, Kibem Kim, Kenneth W. Kinzler, Shibin Zhou, Martin Darvas
Cytokine release syndrome (CRS) is a life-threatening complication of several new immunotherapies used to treat cancers and autoimmune diseases1–5. Here we report that atrial natriuretic peptide can protect mice from CRS induced by such agents by r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b16e85ce60f0808287e34621689f848
https://europepmc.org/articles/PMC6512810/
https://europepmc.org/articles/PMC6512810/
Autor:
Namyoung Jung, Irving L. Weissman, Jun Seita, Kibem Kim, Rudolf Jaenisch, Jacob H. Hanna, Lauren I.R. Ehrlich, K. Ng, Rafael A. Irizarry, Shannon McKinney-Freeman, Akiko Doi, Stuart H. Orkin, T. J. Yoon, George Q. Daley, Hong Ji, Bo Wen, H. Hongguang, Martin J. Aryee, Ralph Weissleder, Olaia Naveiras, Andrew P. Feinberg, Peter Murakami, A. Yabuuchi, A. Takeuchi, Patrick Cahan, Jonghwan Kim, K. C. Cunniff, Rui Zhao
Publikováno v:
Nature, vol 467, iss 7313
Nature
PMC
Nature
PMC
Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming me
Autor:
Zhaobo Li, Kibem Kim, Ada J. Tam, Richard L. Blosser, Luis A. Diaz, Bert Vogelstein, Andrew D. Skora, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Liu Qiang
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 111(32)
Impressive responses have been observed in patients treated with checkpoint inhibitory anti–programmed cell death-1 (PD-1) or anti–cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibodies. However, immunotherapy against poorly immunogenic
Autor:
Kenneth W. Kinzler, Kibem Kim, Lee Blosser, Shibin Zhou, Bert Vogelstein, Luis A. Diaz, Zhaobo Li, Ada Tam, Nickolas Papadopolous, Andrew D. Skora
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Recent clinical trials have shown highly promising responses in a subset of patients treated with immune checkpoint inhibitory anti-programmed cell death-1, anti-programmed cell death ligand-1 (PD-1), and anti-cytotoxic T-lymphocyte